tiprankstipranks
Trending News
More News >
Coherus Biosciences (CHRS)
:CHRS
US Market

Coherus Biosciences (CHRS) Income Statement

Compare
1,637 Followers

Coherus Biosciences Income Statement

Last quarter (Q3 2025), Coherus Biosciences's total revenue was $11.57M, a decrease of -83.65% from the same quarter last year. In Q3, Coherus Biosciences's net income was $-35.53M. See Coherus Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 266.96M$ 257.24M$ 211.04M$ 326.55M$ 475.82M
Gross Profit
$ 149.41M$ 98.25M$ 140.96M$ 268.96M$ 438.16M
Operating Expenses
$ 261.07M$ 301.45M$ 397.84M$ 532.82M$ 281.84M
Depreciation and Amortization
$ 5.28M$ 3.79M$ 3.70M$ 3.45M$ 4.97M
EBITDA
$ 60.94M$ -193.94M$ -255.58M$ -260.69M$ 161.84M
Operating Income
$ -111.67M$ -203.20M$ -256.88M$ -263.86M$ 156.32M
Other Income/Expenses
$ 140.17M$ -35.07M$ -34.87M$ -23.24M$ -20.61M
Pretax Income
$ 28.51M$ -238.27M$ -291.75M$ -287.10M$ 135.71M
Net Income
$ 28.51M$ -237.89M$ -291.75M$ -287.10M$ 132.24M
Per Share Metrics
Basic EPS
$ 0.25$ -2.53$ -3.76$ -3.81$ 1.85
Diluted EPS
$ 0.25$ -2.53$ -3.76$ -3.81$ 1.62
Weighted Average Shares Outstanding
114.55M 94.16M 77.63M 75.45M 71.41M
Weighted Average Shares Outstanding (Diluted)
114.83M 94.16M 77.63M 75.45M 83.49M
Currency in USD

Coherus Biosciences Earnings and Revenue History